Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Shuhei Tara"'
Autor:
Yu Hoshika, Yoshiaki Kubota, Takuya Nishino, Reiko Shiomura, Junsuke Shibuya, Jun Nakata, Hideki Miyachi, Shuhei Tara, Yu‐Ki Iwasaki, Takeshi Yamamoto, Kuniya Asai
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 1995-2000 (2024)
Abstract Aims Plasma volume status (PVS), a measure of plasma volume, has been evaluated as a prognostic marker for chronic heart failure. Although the prognostic value of PVS has been reported, its significance in patients with acute decompensated h
Externí odkaz:
https://doaj.org/article/a41206caf1cd4e2bb3ad77e51d283152
Autor:
Yukihiro Watanabe, Yoshiaki Kubota, Takuya Nishino, Shuhei Tara, Katsuhito Kato, Daisuke Hayashi, Junya Matsuda, Hideki Miyachi, Yukichi Tokita, Yu‐ki Iwasaki, Kuniya Asai
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2043-2054 (2024)
Abstract Aims Fractional excretion of urea nitrogen (FEUN), used to differentiate the cause of acute kidney injury, has emerged as a useful fluid index in patients with heart failure (HF). We hypothesized that FEUN could be useful in identifying wors
Externí odkaz:
https://doaj.org/article/b5bbd4cc6217410eacbade8e6ce639dd
Autor:
Daisuke Hayashi, Yoshiaki Kubota, Takuya Nishino, Yukihiro Watanabe, Yoshiki Iwade, Junya Matsuda, Katsuhito Kato, Shuhei Tara, Yuya Ise, Yu-ki Iwasaki, Kuniya Asai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background Guideline-directed medical therapy (GDMT) is important in heart failure management; however, polypharmacy itself may impact heart failure. Although measures against polypharmacy are needed, current discussion on unilateral drug ta
Externí odkaz:
https://doaj.org/article/d42cfc734c3f43398cd72350238e07b4
Autor:
Yoshiki Iwade, Yoshiaki Kubota, Daisuke Hayashi, Takuya Nishino, Yukihiro Watanabe, Katsuhito Kato, Shuhei Tara, Yuya Ise, Kuniya Asai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-6 (2024)
Abstract Background Pimobendan reportedly improves the subjective symptoms of heart failure. However, evidence of improved prognosis is lacking. This study aimed to determine whether reinforcing guideline-directed medical therapy (GDMT) improved reho
Externí odkaz:
https://doaj.org/article/e95f127bf97745f58b0bb52c3db9794e
Autor:
Shuhei Tara, Christopher K. Breuer, Hirotsugu Kurobe, Kevin A. Rocco, Toshiharu Shinoka, Ethan W. Dean, Brooks V. Udelsman
Over the last decade, advancements in the field of vascular tissue engineering have generated a variety of novel treatment strategies for patients with cardiac defects and vascular disease. Notably, the technique of seeding cells onto biodegradable p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1667d29320032ee0065f6d04d90eeeae
https://doi.org/10.1016/b978-0-12-398523-1.00058-6
https://doi.org/10.1016/b978-0-12-398523-1.00058-6
Autor:
Yukihiro Watanabe, Yoshiaki Kubota, Takuya Nishino, Shuhei Tara, Katsuhito Kato, Daisuke Hayashi, Kosuke Mozawa, Junya Matsuda, Yukichi Tokita, Masahiro Yasutake, Kuniya Asai, Yu‐ki Iwasaki
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1706-1716 (2023)
Abstract Aims Maintenance of euvolaemia with diuretics is critical in heart failure (HF) patients with chronic kidney disease (CKD); however, it is challenging because no reliable marker of volume status exists. Fractional excretion of urea nitrogen
Externí odkaz:
https://doaj.org/article/f1a2ba2eb3a84d369352d039f3d5eb89
Autor:
Kosuke Mozawa, Yoshiaki Kubota, Yu Hoshika, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu‐ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, Kuniya Asai, Masaaki Miyamoto, Yasushi Miyauchi, Eitaro Kodani, Mitsunori Maruyama, Jun Tanabe, Wataru Shimizu
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4161-4173 (2021)
Abstract Aims Although the reno‐protective effects of sodium–glucose cotransporter 2 inhibitors are known in patients with heart failure or type 2 diabetes mellitus (T2DM), this effect has not been confirmed in patients with acute myocardial infa
Externí odkaz:
https://doaj.org/article/22720d5b533447e2bdb3a0064ed8215f
Autor:
Wataru Shimizu, Yoshiaki Kubota, Yu Hoshika, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, Kuniya Asai, Masaaki Miyamoto, Yasushi Miyauchi, Eitaro Kodani, Masahiro Ishikawa, Mitsunori Maruyama, Michio Ogano, Jun Tanabe, EMBODY trial investigators
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-12 (2020)
Abstract Background Protection from lethal ventricular arrhythmias leading to sudden cardiac death (SCD) is a crucial challenge after acute myocardial infarction (AMI). Cardiac sympathetic and parasympathetic activity can be noninvasively assessed us
Externí odkaz:
https://doaj.org/article/d993e2883d2d4205b15f072f7a4d2d68
Autor:
Hideki Miyachi, MD, PhD, Shuhei Tara, MD, PhD, Satoru Otsuru, MD, PhD, Tai Yi, MD, Yong-Ung Lee, PhD, Joseph D. Drews, MD, Hidetaka Nakayama, PhD, Shinka Miyamoto, MD, PhD, Tadahisa Sugiura, MD, PhD, Toshihiro Shoji, BA, Christopher K. Breuer, MD, Toshiharu Shinoka, MD, PhD
Publikováno v:
JVS - Vascular Science, Vol 1, Iss , Pp 57-67 (2020)
Background: Bioresorbable vascular grafts (BVGs) can transform biologically into active blood vessels and represent an alternative to traditional synthetic conduits, which are prone to complications such as infection and thrombosis. Although platelet
Externí odkaz:
https://doaj.org/article/3c6ac0d5f4d545b39b0c37998a746a77
Autor:
Shuhei Tara1 s5062@nms.ac.jp, Takeshi Yamamoto1, Shin Sakai1, Tokuhiro Kimura1, Kazuhiro Asano1, Yuhi Fujimoto1, Reiko Shiomura1, Junya Matsuda1, Kosuke Kadooka1, Kenta Takahashi1, Toshinori Ko1, Hideto Sangen1, Yoshiyuki Saiki1, Jun Nakata1, Yusuke Hosokawa1, Hitoshi Takano2, Wataru Shimizu1,2
Publikováno v:
Journal of Nippon Medical School. 2021, Vol. 88 Issue 5, p432-440. 9p.